微信公众号
证券之星APP
| 报告期 | 销售毛利率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2025-06-30 | 31.51% | -13.97% | 38.86% | 9/131 | 59.33% | 艾德生物 | 84% | 行业排名> |
| 2025-03-31 | 22.69% | -23.02% | -35% | 115/131 | 51.25% | 佰仁医疗 | 85.72% | 行业排名> |
| 2024-12-31 | 34.91% | -6.92% | -0.41% | 102/131 | 52.33% | 佰仁医疗 | 88.34% | 行业排名> |
| 2024-09-30 | 35.05% | -0.08% | -4.3% | 98/131 | 53.43% | 佰仁医疗 | 88.56% | 行业排名> |
| 2024-06-30 | 36.63% | 7.84% | 24.25% | 100/131 | 53.5% | 佰仁医疗 | 89.27% | 行业排名> |
| 2024-03-31 | 29.48% | 1.7% | -21.4% | 105/131 | 53.43% | 佰仁医疗 | 89.28% | 行业排名> |
| 2023-12-31 | 37.5% | -2% | 6.91% | 99/131 | 53.31% | 正海生物 | 89.9% | 行业排名> |
| 2023-09-30 | 35.08% | -2.66% | 3.28% | 97/131 | 54.06% | 正海生物 | 90.39% | 行业排名> |
| 2023-06-30 | 33.96% | -5.29% | 17.18% | 102/131 | 53.45% | 正海生物 | 90.3% | 行业排名> |
| 2023-03-31 | 28.99% | -14.01% | -24.26% | 105/131 | 53.66% | 正海生物 | 89.78% | 行业排名> |
| 2022-12-31 | 38.27% | 2.72% | 6.19% | 99/131 | 53.83% | 三友医疗 | 90.18% | 行业排名> |
| 2022-09-30 | 36.04% | -2.29% | 0.49% | 96/131 | 55.13% | 三友医疗 | 90.14% | 行业排名> |
| 2022-06-30 | 35.86% | 5.21% | 6.39% | 102/131 | 54.78% | 三友医疗 | 90.29% | 行业排名> |
| 2022-03-31 | 33.71% | 2% | -9.52% | 94/131 | 56.28% | 三友医疗 | 90.73% | 行业排名> |
| 2021-12-31 | 37.26% | 12.63% | 1.01% | 108/131 | 57.29% | 三友医疗 | 90.5% | 行业排名> |
| 2021-09-30 | 36.88% | 2% | 8.21% | 92/131 | 59.17% | 三友医疗 | 90.29% | 行业排名> |
| 2021-06-30 | 34.09% | 7.65% | 3.04% | 103/131 | 58.42% | 正海生物 | 90.78% | 行业排名> |
| 2020-12-31 | 33.08% | -7.2% | 4.46% | 114/131 | 59.59% | 正海生物 | 91.59% | 行业排名> |
| 2020-06-30 | 31.66% | 2% | -11.16% | 101/131 | 59.94% | 正海生物 | 92.23% | 行业排名> |
| 2019-12-31 | 35.64% | 2.53% | 2.53% | 95/131 | 56.37% | 正海生物 | 92.69% | 行业排名> |
| 2018-12-31 | 34.76% | 22.8% | 22.8% | 91/131 | 55.53% | 正海生物 | 92.61% | 行业排名> |
| 2017-12-31 | 28.31% | 2% | 2% | 94/131 | 55.34% | 正海生物 | 94.38% | 行业排名> |